207 related articles for article (PubMed ID: 6299543)
1. Epstein-Barr virus-specific leukocyte migration inhibition reaction with tumor biopsy extracts: correlation with the presence of viral DNA.
Szigeti R; Saemundsen AK; Synnerholm AC; Henle G; Henle W; Klein G
Cancer Res; 1983 May; 43(5):2273-6. PubMed ID: 6299543
[TBL] [Abstract][Full Text] [Related]
2. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
Sun N; Chen X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
[TBL] [Abstract][Full Text] [Related]
3. [Epstein-Barr virus DNA in human tumor cells].
Schulte-Holthausen H; zur Hausen H
Zentralbl Bakteriol Orig A; 1972 May; 220(1):47-51. PubMed ID: 4145629
[No Abstract] [Full Text] [Related]
4. Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprints.
Henle W; Henle G; Lanier AP; Bornkamm GW
J Natl Cancer Inst; 1986 Jun; 76(6):1041-6. PubMed ID: 3012176
[TBL] [Abstract][Full Text] [Related]
5. Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors.
Szigeti R; Volsky DJ; Luka J; Klein G
J Immunol; 1981 May; 126(5):1676-9. PubMed ID: 6260854
[TBL] [Abstract][Full Text] [Related]
6. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
[TBL] [Abstract][Full Text] [Related]
7. [Tonsillar cancer and Epstein-Barr virus].
Wilmes E; Wolf H; Haus M
Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):586-9. PubMed ID: 6323895
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
9. Biochemical approaches to detection of Epstein-Barr virus in human tumors.
zur Hausen H
Cancer Res; 1976 Feb; 36(2 pt 2):678-80. PubMed ID: 175925
[TBL] [Abstract][Full Text] [Related]
10. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
Szigeti R; Rabin H; Timar L; Klein G
Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
14. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
15. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
19. Association of Epstein-Barr virus, human papilloma virus, and cytomegalovirus with nine nasopharyngeal carcinoma cell lines.
Lin CT; Dee AN; Chen W; Chan WY
Lab Invest; 1994 Nov; 71(5):731-6. PubMed ID: 7967524
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
